Filtered By:
Condition: Heart Disease
Procedure: Heart Valve Surgery

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 250 results found since Jan 2013.

A Meta-Analysis of Mortality and Major Adverse Cardiovascular and Cerebrovascular Events Following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis
The purpose of this meta-analysis was to compare postprocedural mortality and major adverse cardiovascular and cerebrovascular events between transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) for severe aortic stenosis. Seventeen studies (n = 4,659) comparing TAVI (n = 2,267) and SAVR (n = 2,392) were included. End points were baseline logistic European System for Cardiac Operative Risk Evaluation score, all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, transient ischemic attack, and major bleeding events. Mean differences or risk ratios with 95% conf...
Source: The American Journal of Cardiology - June 6, 2013 Category: Cardiology Authors: Hemang B. Panchal, Vatsal Ladia, Saurabh Desai, Tejaskumar Shah, Vijay Ramu Tags: Valvular Heart Disease Source Type: research

Reoperation on aortic disease in patients with previous aortic valve surgery.
CONCLUSION: To reduce the aortic adverse events after first aortic valve surgery, it is necessary to actively treat and strictly follow-up patients with previous aortic operation especially patients with Marfan syndrome and rheumatic heart disease. PMID: 24034099 [PubMed - in process]
Source: Chinese Medical Journal - September 1, 2013 Category: Journals (General) Authors: Sun XG, Zhang L, Yu CT, Qian XY, Chang Q Tags: Chin Med J (Engl) Source Type: research

High survival rates in trial of new heart valve
Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery. First results from the trial were announced at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco. Results were positive, with high survival rates and low rates of stroke. "This is a major breakthrough," said Fred Leya, MD, co-principal investigator at the Loyola site. "Not only did patients live longer, but their quality of life improved substantially...
Source: Health News from Medical News Today - November 7, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

Using Simple Imaging Markers to Predict Prognosis in Patients With Aortic Valve Stenosis and Unacceptable High Risk for Operation
Aortic valve stenosis (AS) in patients>75 years of age is a challenge for diagnosis and management of every day clinical routine. Therefore, this clinical follow-up study aims to investigate predictors of death in patients with advanced stages of AS. In a single-center study, all patients (n = 157) with primary conservatively treated severe AS (mean age 78 ± 6 years) were included. All patients had initially refused aortic valve replacement (AVR). During a median follow-up of 2.6 years (quartiles 1.7, 3.8), 62 patients with severe AS switched to AVR and 95 remained conservatively treated (no AVR). Routine clinical data...
Source: The American Journal of Cardiology - September 9, 2013 Category: Cardiology Authors: Sebastian Herrmann, Bart Bijnens, Stefan Störk, Markus Niemann, Kai Hu, Dan Liu, Robin Kettner, Daniel Rau, Jörg Strotmann, Wolfram Voelker, Georg Ertl, Frank Weidemann Tags: Valvular Heart Disease Source Type: research

AANA Journal Course: Update for nurse aneshtetists--part-4--transcatheter aortic valve replacement.
Abstract Aortic stenosis is the most frequently acquired heart disease, and the prevalence is rising because of the aging population. If the disease is left untreated, survival in symptomatic patients averages only 2 to 3 years. Surgical aortic valve replacement is the only definitive treatment, yet 30% of elderly patients are not considered candidates because the presence of comorbidities makes the risk of sternotomy and cardiopulmonary bypass prohibitively high. Transcatheter aortic valve replacement (TAVR) is an innovative, high-tech, less invasive alternative. The procedure is usually performed using general a...
Source: AANA Journal - October 1, 2013 Category: Anesthesiology Authors: Contrera P, Cushing M Tags: AANA J Source Type: research

Outcome of Transcatheter Aortic Valve Implantation in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
In conclusion, transcatheter aortic valve implantation appears to result in similar hemodynamic and long-term clinical outcomes for high-risk surgical patients with LGSAS as those with typical severe AS.
Source: The American Journal of Cardiology - November 8, 2013 Category: Cardiology Authors: Simon Biner, Edo Yaakov Birati, Yan Topilsky, Arie Steinvil, Eyal Ben Assa, Ben Sadeh, Yaron Arbel, Amir Halkin, Yigal Abramowitz, Eran Leshem-Rubinow, Shmuel Banai, Gad Keren, Ariel Finkelstein Tags: Valvular Heart Disease Source Type: research

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes
Background: The use of balloon aortic valvuloplasty (BAV) has resurged since the development of transcatheter aortic valve replacement (TAVR). The aim of our study was to determine the procedural and long-term outcomes of patients treated by BAV in the early TAVR era.Methods: From 2005 to 2008, 323 consecutive patients presenting with severe aortic stenosis were treated by BAV in our institution.Results: Mean age and logistic EuroSCORE were 80.5 ± 9.9 years and 28.7% ± 12.5%, respectively. The effective orifice area increased from 0.68 ± 0.25 to 1.12 ± 0.39 cm2 (P
Source: American Heart Journal - November 6, 2013 Category: Cardiology Authors: Hélène Eltchaninoff, Eric Durand, Bogdan Borz, Akira Furuta, Karim Bejar, Alexandre Canville, Ali Farhat, Chiara Fraccaro, Matthieu Godin, Christophe Tron, Rahul Sakhuja, Alain Cribier Tags: Valvular and Congenital Heart Disease Source Type: research

Comparison of Echocardiographic and Pressure–volume Loop Indices of Systolic Function in Patients with Single Ventricle Physiology: A Preliminary Report
ConclusionsObtaining PVLs via microconductance catheters can reliably be performed in the single ventricle population and serve as a method to validate echocardiographic indices in this high‐risk population. Of the echocardiographic variables, FAC showed the best correlation with PVL indices. Future studies controlling for stage of palliation should be performed to further validate echocardiographic measures of systolic function in this patient population.
Source: Congenital Heart Disease - May 28, 2014 Category: Cardiology Authors: Ryan J. Butts, Shahryar M. Chowdhury, Jason Buckley, Anthony M. Hlavacek, Tain Yen Hsia, Sachin Khambadkone, G. Hamilton Baker, Tags: Original Article Source Type: research

Cardiac Surgery in Indigenous Australians: Early Onset Cardiac Disease with follow-up Challenges
Conclusions: The mean age of 52 years at which Indigenous patients have cardiac surgery is significantly low compared to non-Indigenous patients. Indigenous patients have multiple risk factors for cardiac disease and with a large number requiring emergency surgery. Although surgical outcome in the short term is favourable, a large number of patients are lost to follow-up. The use of mechanical valve and warfarin should be individualised. Strategic post-operative follow-up mechanisms are needed to address these issues.
Source: Heart, Lung and Circulation - February 24, 2014 Category: Cardiology Authors: M.P. Matebele, S. Rohde, A. Clarke, J.F. Fraser Tags: Original Articles Source Type: research

Asymptomatic adults with mild/moderate isolated native pulmonary valve stenosis are in need of treatment... but not the kind you are thinking of!
As new treatment strategies are developed which outperform previous approaches in terms of safety, efficacy and long-term results, a reappraisal of old therapeutic dogmas is warranted, including lowering the threshold for intervention. Pulmonary valvuloplasty was introduced in 1982 to treat children and adults with significant isolated pulmonary valve stenosis (PS) and provided a very reliable tool to treat the problem avoiding cardiac surgery, with very good long-term results in terms of reinterventions as well as functional outcomes.1 2 Besides the neonate with critical PS, the same technique has been used to treat older...
Source: Heart - August 6, 2014 Category: Cardiology Authors: Giardini, A., Cervi, E. Tags: Congenital heart disease, Drugs: cardiovascular system, Hypertension, Interventional cardiology, Right sided valvular heart disease Editorials Source Type: research

Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice
Conclusion Severe aortic stenosis is associated with increased risk of MACE. In contemporary practice, perioperative mortality of patients with SAS is lower than previously reported and the difference from controls did not reach statistical significance. Emergency surgery is the strongest predictor of post-operative death. These results have implications for perioperative risk assessment and management strategies in patients with SAS.
Source: European Heart Journal - September 14, 2014 Category: Cardiology Authors: Tashiro, T., Pislaru, S. V., Blustin, J. M., Nkomo, V. T., Abel, M. D., Scott, C. G., Pellikka, P. A. Tags: Valvular heart disease Source Type: research

Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves
Conclusion The aortic valve weight data reported in this study provide evidence that a large proportion of patients with PLF and low-gradient have a severe stenosis and that the gradient may substantially underestimate stenosis severity in these patients. A multi-parametric approach including all Doppler-echocardiographic parameters of valve function as well as other complementary diagnostic tests may help correctly identify these patients.
Source: European Heart Journal - October 7, 2014 Category: Cardiology Authors: Clavel, M.-A., Cote, N., Mathieu, P., Dumesnil, J. G., Audet, A., Pepin, A., Couture, C., Fournier, D., Trahan, S., Page, S., Pibarot, P. Tags: Valvular heart disease Source Type: research

P113 * Clinical outcomes following double and triple valve surgery in Hong Kong
Conclusion: Patient requiring double and triple valve surgeries represent a heterogeneous and complex group of patients. They are a significant portion of patients undergoing valve surgery in our Institution. Outcomes in comparison to pre-operative risk scores and International Databases are satisfactory.
Source: European Journal of Heart Failure Supplements - February 23, 2012 Category: Cardiology Authors: Wong, H. L., Ng, S. H., Kwok, W. T., Yeung, C. L., Yu, S. Y., Wan, Y. P., Wan, S., Underwood, M. J., Bai, W. J., Li, H., Tang, H., Wang, H., Rao, L., Li, H., Bai, W. J., Chen, Y., Tang, H., Peng, Y., Rao, L., Park, Y. H., Han, D. C., Sohn, C. B., Kim, J. Tags: Valvular Heart Disease Source Type: research

Short-Term Results of Transapical Transcatheter Mitral Valve Implantation for Mitral Regurgitation
ConclusionsTransapical transcatheter mitral valve implantation is technically feasible and can be performed safely. Early hemodynamic performance of the prosthesis was excellent. Transcatheter mitral valve implantation may become an important treatment option for patients with severe MR who are at high operative risk.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - October 20, 2014 Category: Cardiology Source Type: research